NCT03637283 is a NA clinical trial of anti-VEGF in Anti-VEGF, sponsored by Wenzhou Medical University.

Who is sponsoring NCT03637283?

NCT03637283 is sponsored by Wenzhou Medical University.

What drugs are being tested in NCT03637283?

Interventions in NCT03637283: anti-VEGF, fan-shaped photocoagulation.

What condition does NCT03637283 study?

NCT03637283 studies Anti-VEGF, Branch Retinal Vein Occlusion, Vitrectomy.

Is NCT03637283 still recruiting?

NCT03637283 is currently status unknown. Last updated 17 August 2018.

Last reviewed 2018-08-17 · How we verify

NCT03637283

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Anti-VEGF Instead of Intraoperative Fan-shaped Photocoagulation in BRVO Combined With Vitreous Hemorrhage

Status unknown NA Last updated 17 August 2018

What this trial tests

NA trial testing anti-VEGF in Anti-VEGF in 100 participants. Status unknown.

Timeline

1 October 2018

Primary endpoint
1 December 2020

1 December 2021

Quick facts

Lead sponsor	Wenzhou Medical University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	1 October 2018
Primary completion	1 December 2020
Estimated completion	1 December 2021

Drugs / interventions tested

anti-VEGF (anti-vegf) — full drug profile →
fan-shaped photocoagulation

Conditions studied

Anti-VEGF — all drugs for Anti-VEGF →
Branch Retinal Vein Occlusion — all drugs for Branch Retinal Vein Occlusion →
Vitrectomy — all drugs for Vitrectomy →

Sponsor

Wenzhou Medical University

Who can join

Adults 18 to 80, any sex, with Anti-VEGF or Branch Retinal Vein Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the efficacy and safety of Anti-VEGF instead of intraoperative fan-shaped photocoagulation in BRVO combined with vitreous hemorrhage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of anti-VEGF

Trials testing the same drug.

NCT05156021 — A Study on the Treatment Strategy of NVG Secondary to PDR · NA · completed
NCT03633266 — Anti-VEGF Instead of Intraoperative PRP in Proliferative Diabetic Retinopathy · NA · unknown

Other Wenzhou Medical University trials

Trials by the same sponsor.

NCT06905938 — Comparing Monofocal IOLs in Highly Myopic Cataract Patients · not yet recruiting
NCT06892470 — Visual Quality of Cataract Patients with High Myopia After Implantation of Different Intraocular Lenses · active not recruiting
NCT06751342 — Using Psychophysics Methods to Investigate Sensory Dominance After Cataract Surgery · active not recruiting
NCT06707740 — Comparison of the Effect of Capsular Bend on the Rotational Stability Between Two Toric Intraocular Lenses · active not recruiting
NCT06091722 — Quantitative Assessment of Lid Margin Vascularity Using SS-OCTA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03637283 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wenzhou Medical University
Last refreshed: 17 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03637283.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing